NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 4MVJ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 4MVJ_NAD_I_401 | 64% | 24% | 0.132 | 0.934 | 1.39 | 1.6 | 7 | 10 | 0 | 0 | 100% | 0.5 |
| 4MVJ_NAD_E_401 | 53% | 24% | 0.15 | 0.912 | 1.25 | 1.75 | 4 | 13 | 0 | 0 | 100% | 0.5 |
| 4MVJ_NAD_P_401 | 52% | 22% | 0.143 | 0.901 | 1.44 | 1.69 | 8 | 16 | 2 | 0 | 100% | 0.5 |
| 4MVJ_NAD_O_401 | 52% | 20% | 0.15 | 0.908 | 1.31 | 1.91 | 6 | 11 | 4 | 0 | 100% | 0.5 |
| 4MVJ_NAD_C_401 | 47% | 15% | 0.117 | 0.854 | 1.77 | 1.9 | 9 | 14 | 4 | 0 | 100% | 1 |
| 4MVJ_NAD_D_401 | 43% | 23% | 0.167 | 0.894 | 1.3 | 1.78 | 6 | 16 | 3 | 0 | 100% | 0.5 |
| 4MVJ_NAD_K_401 | 38% | 20% | 0.166 | 0.868 | 1.39 | 1.85 | 7 | 15 | 4 | 0 | 100% | 0.5 |
| 2VYN_NAD_D_1341 | 98% | 19% | 0.045 | 0.977 | 1.72 | 1.61 | 7 | 8 | 1 | 0 | 100% | 1 |
| 1DC6_NAD_B_352 | 88% | 11% | 0.069 | 0.951 | 2.35 | 1.75 | 9 | 10 | 2 | 0 | 100% | 1 |
| 2VYV_NAD_D_1340 | 58% | 19% | 0.102 | 0.878 | 1.8 | 1.54 | 6 | 9 | 3 | 0 | 100% | 1 |
| 1DBV_NAD_O_336 | 100% | 18% | 0.012 | 0.999 | 1.39 | 1.98 | 5 | 12 | 0 | 0 | 100% | 1 |
| 1HZJ_NAD_A_400 | 100% | 22% | 0.009 | 0.999 | 1.43 | 1.7 | 8 | 8 | 1 | 0 | 100% | 1 |
| 1OWB_NAD_A_3000 | 100% | 7% | 0.015 | 0.998 | 2.36 | 2.37 | 10 | 13 | 1 | 0 | 100% | 1 |
| 2NAD_NAD_B_394 | 100% | 7% | 0.016 | 0.997 | 2.25 | 2.54 | 14 | 23 | 3 | 0 | 100% | 1 |
| 2QG4_NAD_F_500 | 100% | 19% | 0.017 | 0.998 | 1.81 | 1.58 | 4 | 9 | 0 | 0 | 100% | 1 |